RRC ID 72212
著者 Nittayaboon K, Leetanaporn K, Sangkhathat S, Roytrakul S, Navakanitworakul R.
タイトル Cytotoxic effect of metformin on butyrate-resistant PMF-K014 colorectal cancer spheroid cells.
ジャーナル Biomed Pharmacother
Abstract Three-dimensional (3D) cell culture models are used in cancer research because they mimic physiological responses in vivo compared with two-dimensional (2D) culture systems. Recently, cross-resistance of butyrate-resistant (BR) cells and chemoresistance in colorectal cancer (CRC) cells have been reported; however, effective treatments for BR cells have not been identified. In this study, we investigated the cytotoxicity of metformin (MET), an anti-diabetic drug, on BR CRC cells in a 3D spheroid culture model. The results demonstrate that MET decreases spheroid size, migration, and spheroid viability, while it increases spheroid death. The molecular mechanism revealed that AMP-activated protein kinase (AMPK) and Akt serine/threonine kinase 1(Akt) were significantly upregulated, whereas the acetyl-CoA-carboxylase (ACC) and mammalian target of rapamycin (mTOR) were downregulated, which led to caspase activation and apoptosis. Our findings show the potential cytotoxicity of MET on CRC-BR cells. The combination of MET and conventional chemotherapeutic drugs should be addressed in further studies to reduce the side effects of standard chemotherapy for CRC.
巻・号 151
ページ 113214
公開日 2022-7-1
DOI 10.1016/j.biopha.2022.113214
PII S0753-3322(22)00603-5
PMID 35676792
MeSH AMP-Activated Protein Kinases / metabolism Antineoplastic Agents* / pharmacology Antineoplastic Agents* / therapeutic use Butyrates / pharmacology Butyrates / therapeutic use Cell Line, Tumor Colorectal Neoplasms* / drug therapy Humans Metformin* / pharmacology Metformin* / therapeutic use Proto-Oncogene Proteins c-akt / metabolism
IF 4.545
リソース情報
ヒト・動物細胞 PMF-ko14(RCB1426)